Early identification and prevention of cardiometabolic risk in Gulf Cooperation Council countries: a scoping review relevant to primary care and family medicine.
7 affiliations
- 1Department of Family and Community Medicine, College of Medicine, Jouf University, Sakaka, Aljouf, Saudi Arabia.
- 2Department of Internal Medicine, College of Medicine, Jouf University, Sakaka, Aljouf, Saudi Arabia.
- 3Department of Clinical Pharmacy, College of Pharmacy, Jouf University, Sakaka, Aljouf, Saudi Arabia.
- 4Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, Aljouf, Saudi Arabia.
- 5Department of Cardiology, Aljouf Cardiac Center, Aljouf Health cluster, Sakaka, Aljouf, Saudi Arabia.
- 6Department of Family and Community Medicine, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
- 7Department of Medicine, College of Medicine, Qassim university, Qassim, Saudi Arabia.
Abstract
Objectives
This scoping review was aimed at mapping and identifying the current evidence on the early identification and prevention of cardiometabolic risks in Gulf Cooperation Council countries, in the context of primary care and family medicine, and to identify where evidence is concentrated or absent.Methods
Original studies in English were searched in PubMed/MEDLINE, Scopus, and Web of Science, between January 2020 and February 2026. The eligible studies were conducted in Gulf Cooperation Council countries and focused on cardiometabolic risk, early identification, screening, prevention, risk reduction, lifestyle interventions, health education, or preventive strategies. Data were charted using a structured form and synthesised descriptively.Results
The evidence indicated that the high and clustered burden of dysglycemia, prediabetes, diabetes, metabolic syndrome, hypertension, dyslipidemia, and central obesity existed among adults, children, adolescents, university students, community populations, primary care settings, and biobank-based studies. Studies demonstrated the value of risk scores, anthropometric measurements, biomarkers, and community screening strategies. Prevention and early-intervention studies were less frequently represented and heterogeneous across settings.Conclusion
Current Gulf Cooperation Council evidence supports the importance of early cardiometabolic risk identification and prevention but also highlights the need for integrated prevention pathways within primary care and family medicine.
Related
- Out-of-pocket health expenditure and the health financing mix in Gulf Cooperation Council countries, 2000–2023: a descriptive analysis of WHO data
- Cardiometabolic Risk Trajectories in Young Adults Across 16 Middle East and North African Countries, 1990-2018: A Sex-Asymmetric Divergence
- Excess adiposity and early cardiometabolic risk markers among adolescents and young adults in 70 countries: a multi-country cross-sectional study
- Optimising HPV Vaccination for Cervical Cancer Prevention in Women Living with HIV: A Cost-Effectiveness Analysis Across 13 African Countries
- Global Trends in Cardiovascular Mortality and Major Cardiometabolic Risk Factors, 2000 to 2023: A Longitudinal Ecological Analysis of 204 Countries and Territories
BibTeX
@article{alsaidan2026early,
title = {{Early identification and prevention of cardiometabolic risk in Gulf Cooperation Council countries: a scoping review relevant to primary care and family medicine.}},
author = {Aseel Awad Alsaidan and Bashayer Farhan Alruwaili and Muhannad Almubarak and Abdulaziz Ibrahim Alzarea and Hassan H Alhassan and Ali Farhan Alanazi and Rami Hamdan Alharbi and Ali M Alzweihary},
journal = {Preventive medicine reports},
year = {2026},
month = oct,
doi = {10.1016/j.pmedr.2026.103662},
url = {https://europepmc.org/article/MED/42909059},
note = {CC BY},
}
RIS
TY - JOUR
TI - Early identification and prevention of cardiometabolic risk in Gulf Cooperation Council countries: a scoping review relevant to primary care and family medicine.
AU - Aseel Awad Alsaidan
AU - Bashayer Farhan Alruwaili
AU - Muhannad Almubarak
AU - Abdulaziz Ibrahim Alzarea
AU - Hassan H Alhassan
AU - Ali Farhan Alanazi
AU - Rami Hamdan Alharbi
AU - Ali M Alzweihary
PY - 2026
DA - 2026/10/12
JO - Preventive medicine reports
DO - 10.1016/j.pmedr.2026.103662
UR - https://europepmc.org/article/MED/42909059
AB - Objectives This scoping review was aimed at mapping and identifying the current evidence on the early identification and prevention of cardiometabolic risks in Gulf Cooperation Council countries, in the context of primary care and family medicine, and to identify where evidence is concentrated or absent.Methods Original studies in English were searched in PubMed/MEDLINE, Scopus, and Web of Science, between January 2020 and February 2026. The eligible studies were conducted in Gulf Cooperation Council countries and focused on cardiometabolic risk, early identification, screening, prevention, risk reduction, lifestyle interventions, health education, or preventive strategies. Data were charted using a structured form and synthesised descriptively.Results The evidence indicated that the high and clustered burden of dysglycemia, prediabetes, diabetes, metabolic syndrome, hypertension, dyslipidemia, and central obesity existed among adults, children, adolescents, university students, community populations, primary care settings, and biobank-based studies. Studies demonstrated the value of risk scores, anthropometric measurements, biomarkers, and community screening strategies. Prevention and early-intervention studies were less frequently represented and heterogeneous across settings.Conclusion Current Gulf Cooperation Council evidence supports the importance of early cardiometabolic risk identification and prevention but also highlights the need for integrated prevention pathways within primary care and family medicine.
SN - 2211-3355
ER -